在发展中世界平衡艾滋病治疗的有效性与可及性。 - Suppr

Suppr

超能文献

Balancing effectiveness and access to HIV treatment in the developing world.

作者信息

Hill Andrew, Wood Evan

机构信息

Pharmacology Research Laboratories, University of Liverpool, 70 Pembroke Place, Liverpool, UK.

出版信息

AIDS. 2007 Jan 30;21(3):361-3. doi: 10.1097/QAD.0b013e328012c560.

DOI:10.1097/QAD.0b013e328012c560

PMID:17255743

Abstract

摘要

相似文献

Balancing effectiveness and access to HIV treatment in the developing world.

AIDS. 2007 Jan 30;21(3):361-3. doi: 10.1097/QAD.0b013e328012c560.

Providing antiretroviral therapy for HIV infection.

N Engl J Med. 2001 Mar 15;344(11):844-6. doi: 10.1056/NEJM200103153441112.

Inequalities in health: access to treatment for HIV/AIDS.

Ann Ist Super Sanita. 2007;43(4):313-6.

The economics of effective AIDS treatment in Thailand.

AIDS. 2007 Jul;21 Suppl 4:S105-16. doi: 10.1097/01.aids.0000279713.39675.1c.

Access to HIV drugs: are we changing the two world paradigm?

Conn J Int Law. 2002 Spring;17(2):281-96.

Sustaining treatment costs: who will pay?

AIDS. 2007 Jul;21 Suppl 4:S1-4. doi: 10.1097/01.aids.0000279700.86309.f6.

HAART--the need for strategically focused investments.

Bull World Health Organ. 2001;79(12):1152-3.

The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.

Chic J Int Law. 2002 Spring;3(1):105-14.

Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.

Trop Med Int Health. 2008 Oct;13(10):1245-56. doi: 10.1111/j.1365-3156.2008.02142.x. Epub 2008 Aug 20.

The price of HIV treatment.

Neth J Med. 2003 Dec;61(12):391-2.

引用本文的文献

Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):475-81. doi: 10.1097/QAI.0b013e31823058a3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Balancing effectiveness and access to HIV treatment in the developing world.

AIDS. 2007 Jan 30;21(3):361-3. doi: 10.1097/QAD.0b013e328012c560.

Providing antiretroviral therapy for HIV infection.

N Engl J Med. 2001 Mar 15;344(11):844-6. doi: 10.1056/NEJM200103153441112.

Inequalities in health: access to treatment for HIV/AIDS.

Ann Ist Super Sanita. 2007;43(4):313-6.

The economics of effective AIDS treatment in Thailand.

AIDS. 2007 Jul;21 Suppl 4:S105-16. doi: 10.1097/01.aids.0000279713.39675.1c.

Access to HIV drugs: are we changing the two world paradigm?

Conn J Int Law. 2002 Spring;17(2):281-96.

Sustaining treatment costs: who will pay?

AIDS. 2007 Jul;21 Suppl 4:S1-4. doi: 10.1097/01.aids.0000279700.86309.f6.

HAART--the need for strategically focused investments.

Bull World Health Organ. 2001;79(12):1152-3.

The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.

Chic J Int Law. 2002 Spring;3(1):105-14.

Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.

Trop Med Int Health. 2008 Oct;13(10):1245-56. doi: 10.1111/j.1365-3156.2008.02142.x. Epub 2008 Aug 20.

The price of HIV treatment.

Neth J Med. 2003 Dec;61(12):391-2.

引用本文的文献

Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):475-81. doi: 10.1097/QAI.0b013e31823058a3.